Genfit Sa logo

Genfit Sa Share Price (NASDAQ: GNFT)

$4.01

-0.05

(-1.23%)

Last updated on

Check the interactive Genfit Sa Stock chart to analyse performance

Genfit Sa Key Stats

Check Genfit Sa key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.06
Open
$4.32
Market Capitalization
$202.9M
Today's Volume
$1.2K
Revenue TTM
$70.7M
EBITDA
$4.7M
Earnings Per Share (EPS)
$0.03
PE Ratio
133.33
Profit Margin
2.13%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
2.2%

Stock Returns calculator for Genfit Sa Stock including INR - Dollar returns

The Genfit Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Genfit Sa investment value today

Current value as on today

₹97,680

Returns

₹2,320

(-2.32%)

Returns from Genfit Sa Stock

₹7,604 (-7.6%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Genfit Sa Stock

0%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Genfit Sa Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Genfit Sa

  • Name

    Holdings %

  • Millennium Management LLC

    0.26%

  • Morgan Stanley - Brokerage Accounts

    0.05%

  • Optiver Holding B.V.

    0.03%

  • Citadel Advisors Llc

    0.02%

  • UBS Group AG

    0.01%

Analyst Recommendation on Genfit Sa Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Genfit Sa(by analysts ranked 0 to 5 stars)

Genfit Sa Share Price Target

What analysts predicted

Upside of 124.84%

Target:

$9.02

Current:

$4.01

Genfit Sa share price target is $9.02, a slight Upside of 124.84% compared to current price of $4.01 as per analysts' prediction.

Genfit Sa Stock Insights

  • Price Movement

    In the last 7 days, GNFT stock has moved down by -7.3%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 2.81M → 61.10M (in $), with an average increase of 59.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -8.04M → 30.31M (in $), with an average increase of 101.5% per quarter
  • GNFT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 76.3%
  • GNFT vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 115.2%
  • Price to Sales

    ForGNFT every $1 of sales, investors are willing to pay $3.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Genfit Sa Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$70.1M
↑ 134.56%
Net Income
$1.6M
↓ 105.22%
Net Profit Margin
2.25%
↑ 103.4%

Genfit Sa Technicals Summary

Sell

Neutral

Buy

Genfit Sa is currently in a neutral trading position according to technical analysis indicators.

Genfit Sa Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Genfit Sa logo
3.22%
19.47%
-0.93%
-3.52%
-15.02%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Genfit Sa

Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2a trial to treat patients with cholangiocarcinoma (CCA); VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia; CML-022; SRT-015, an ASK1 inhibitor targets the inhibition of cellular apoptosis, inflammation, and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.
Organization
Genfit Sa
Employees
180
CEO
Mr. M. Pascal Prigent
Industry
Biotechnology

Key Management of Genfit Sa

NameTitle
Mr. Jean-Francois Mouney
Co-Founder & Chairman of the Board
Mr. M. Pascal Prigent
Chief Executive Officer
Prof. Bart Staels
Co-Founder & Chairman of the Scientific Advisory Board
Mr. Thomas Baetz
Chief Financial Officer
Mr. Pascal Caisey
Chief Operating Officer
Dr. Dean W. Hum Ph.D.
Chief Scientific Officer
Mr. Jean-Christophe Marcoux
Chief Corporate Affairs Officer, Head of Investor Relations & Head of ESG
Mr. Laurent Lannoo
Corporate Secretary & Director of Legal Affairs
Ms. Stefanie Magner J.D.
Chief Compliance Officer & Executive VP of International Legal Affairs
Ms. Emilie Desodt
Executive Vice President of Human Resources

Important FAQs about investing in GNFT Stock from India :

What is Genfit Sa share price today?

Genfit Sa share price today is $4.01 as on at the close of the market. Genfit Sa share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Genfit Sa share?

Genfit Sa share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Genfit Sa stock price today i.e. is closed at $4.01, lower by 37.57% versus the 52 week high.

How to invest in Genfit Sa Stock (GNFT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Genfit Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genfit Sa Shares that will get you 0.3741 shares as per Genfit Sa share price of $4.01 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Genfit Sa Stock (GNFT) from India?

Indian investors can start investing in Genfit Sa (GNFT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Genfit Sa stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Genfit Sa share’s latest price of $4.01 as on August 30, 2025 at 1:28 am IST, you will get 2.4938 shares of Genfit Sa. Learn more about fractional shares .

What are the returns that Genfit Sa has given to Indian investors in the last 5 years?

Genfit Sa stock has given -15.02% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?